BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 29250567)

  • 21. Evaluation of PET quantitation accuracy among multiple discovery IQ PET/CT systems via NEMA image quality test.
    Vallot D; De Ponti E; Morzenti S; Gramek A; Pieczonka A; Llompart GR; Siennicki J; Deak P; Dutta C; Uribe J; Caselles O
    EJNMMI Phys; 2020 May; 7(1):30. PubMed ID: 32399647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overview of the clinical effectiveness of positron emission tomography imaging in selected cancers.
    Facey K; Bradbury I; Laking G; Payne E
    Health Technol Assess; 2007 Oct; 11(44):iii-iv, xi-267. PubMed ID: 17999839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multi-site quality and variability analysis of 3D FDG PET segmentations based on phantom and clinical image data.
    Beichel RR; Smith BJ; Bauer C; Ulrich EJ; Ahmadvand P; Budzevich MM; Gillies RJ; Goldgof D; Grkovski M; Hamarneh G; Huang Q; Kinahan PE; Laymon CM; Mountz JM; Muzi JP; Muzi M; Nehmeh S; Oborski MJ; Tan Y; Zhao B; Sunderland JJ; Buatti JM
    Med Phys; 2017 Feb; 44(2):479-496. PubMed ID: 28205306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variability and uncertainty of 18F-FDG PET imaging protocols for assessing inflammation in atherosclerosis: suggestions for improvement.
    Huet P; Burg S; Le Guludec D; Hyafil F; Buvat I
    J Nucl Med; 2015 Apr; 56(4):552-9. PubMed ID: 25722452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Qualification of PET scanners for use in multicenter cancer clinical trials: the American College of Radiology Imaging Network experience.
    Scheuermann JS; Saffer JR; Karp JS; Levering AM; Siegel BA
    J Nucl Med; 2009 Jul; 50(7):1187-93. PubMed ID: 19525463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation.
    Brush J; Boyd K; Chappell F; Crawford F; Dozier M; Fenwick E; Glanville J; McIntosh H; Renehan A; Weller D; Dunlop M
    Health Technol Assess; 2011 Sep; 15(35):1-192, iii-iv. PubMed ID: 21958472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variations in PET/CT methodology for oncologic imaging at U.S. academic medical centers: an imaging response assessment team survey.
    Graham MM; Badawi RD; Wahl RL
    J Nucl Med; 2011 Feb; 52(2):311-7. PubMed ID: 21233185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The (68)Ge phantom-based FDG-PET site qualification program for clinical trials adopted by FIL (Italian Foundation on Lymphoma).
    Chauvie S; Bergesio F; Fioroni F; Brambilla M; Biggi A; Versari A; Guerra L; Storto G; Musto P; Luminari S; Cabras MG; Balzarotti M; Rigacci L; Martelli M; Vitolo U; Federico M; Gallamini A
    Phys Med; 2016 May; 32(5):651-6. PubMed ID: 27133138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Test-Retest Reproducibility of
    Kurland BF; Peterson LM; Shields AT; Lee JH; Byrd DW; Novakova-Jiresova A; Muzi M; Specht JM; Mankoff DA; Linden HM; Kinahan PE
    J Nucl Med; 2019 May; 60(5):608-614. PubMed ID: 30361381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calibration Software for Quantitative PET/CT Imaging Using Pocket Phantoms.
    Zukić D; Byrd DW; Kinahan PE; Enquobahrie A
    Tomography; 2018 Sep; 4(3):148-158. PubMed ID: 30320214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Post-acquisition Standardization of Positron Emission Tomography Images.
    Mortazi A; Udupa JK; Odhner D; Tong Y; Torigian DA
    Res Sq; 2023 Jan; ():. PubMed ID: 36711962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are lesion features reproducible between
    Constantino CS; Oliveira FPM; Silva M; Oliveira C; Castanheira JC; Silva Â; Vaz SC; Vieira P; Costa DC
    Eur Radiol; 2021 May; 31(5):3071-3079. PubMed ID: 33125562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical interpretation standards and quality assurance for the multicenter PET/CT trial rubidium-ARMI.
    Renaud JM; Mylonas I; McArdle B; Dowsley T; Yip K; Turcotte E; Guimond J; Trottier M; Pibarot P; Maguire C; Lalonde L; Gulenchyn K; Wisenberg G; Wells RG; Ruddy T; Chow B; Beanlands RS; deKemp RA
    J Nucl Med; 2014 Jan; 55(1):58-64. PubMed ID: 24249797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimizing positron emission tomography image acquisition protocols in integrated positron emission tomography/magnetic resonance imaging.
    Hartung-Knemeyer V; Beiderwellen KJ; Buchbender C; Kuehl H; Lauenstein TC; Bockisch A; Poeppel TD
    Invest Radiol; 2013 May; 48(5):290-4. PubMed ID: 23399811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dynamic whole-body PET parametric imaging: I. Concept, acquisition protocol optimization and clinical application.
    Karakatsanis NA; Lodge MA; Tahari AK; Zhou Y; Wahl RL; Rahmim A
    Phys Med Biol; 2013 Oct; 58(20):7391-418. PubMed ID: 24080962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Positron emission tomography/computerised tomography imaging in detecting and managing recurrent cervical cancer: systematic review of evidence, elicitation of subjective probabilities and economic modelling.
    Meads C; Auguste P; Davenport C; Małysiak S; Sundar S; Kowalska M; Zapalska A; Guest P; Thangaratinam S; Martin-Hirsch P; Borowiack E; Barton P; Roberts T; Khan K
    Health Technol Assess; 2013 Mar; 17(12):1-323. PubMed ID: 23537558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Added Value of Respiratory Gating in Positron Emission Tomography for the Clinical Management of Lung Cancer Patients.
    Grootjans W; Rietbergen DDD; van Velden FHP
    Semin Nucl Med; 2022 Nov; 52(6):745-758. PubMed ID: 35643531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multicenter Clinical Trials Using 18F-FDG PET to Measure Early Response to Oncologic Therapy: Effects of Injection-to-Acquisition Time Variability on Required Sample Size.
    Kurland BF; Muzi M; Peterson LM; Doot RK; Wangerin KA; Mankoff DA; Linden HM; Kinahan PE
    J Nucl Med; 2016 Feb; 57(2):226-30. PubMed ID: 26493206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Total-body
    Hu P; Zhang Y; Yu H; Chen S; Tan H; Qi C; Dong Y; Wang Y; Deng Z; Shi H
    Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2384-2394. PubMed ID: 33866409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual-Energy Computed Tomography-Based Iodine Quantitation for Response Evaluation of Lung Cancers to Chemoradiotherapy/Radiotherapy: A Comparison With Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography-Based Positron Emission Tomography/Computed Tomography Response Evaluation Criterion in Solid Tumors.
    Ren Y; Jiao Y; Ge W; Zhang L; Hua Y; Li C; Zhai W; Tang X; He W; Fang M; Zheng X
    J Comput Assist Tomogr; 2018; 42(4):614-622. PubMed ID: 29613988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.